FDA OKs First Rifabutin-Based H Pylori Therapy Talicia FDA OKs First Rifabutin-Based H Pylori Therapy Talicia
Talicia combines omeprazole, amoxicillin, and rifabutin and is designed to address growing bacterial resistance to standard clarithromycin-based H pylori therapy.FDA Approvals (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 4, 2019 Category: Intensive Care Tags: Infectious Diseases News Alert Source Type: news
Most Americans Who Think They ’ re Allergic to Penicillin Aren ’ t, Study Finds
BOSTON (CBS)- Think you’re allergic to penicillin? Chances are…you’re not. In fact, more than 30 million people in the United States wrongly believe they’re allergic to penicillin.
Many people report that they’re allergic to penicillin, or amoxicillin, or one of the other penicillin’s, often saying they’re mom told them they had some type of reaction when they were little.
So many doctors turn to other types of antibiotics to treat common ailments like strep throat or ear infections, which may be more expensive, have more side effects, and could contribute to greater antibiotic...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 30, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated CBSN Boston Syndicated Local Allergies Dr. Mallika Marshall Health Watch penicillin penicillin allergy Source Type: news
Efficacy of antibiotic treatment in patients with chronic low back pain and Modic changes (the AIM study): double blind, randomised, placebo controlled, multicentre trial
In this study on patients with chronic low back pain and Modic changes at the level of a previous disc herniation, three months of treatment with amoxicillin did not provide a clinically important benefit compared with placebo. Secondary analyses and sensitivity analyses supported this finding. Therefore, the results do not support the use of antibiotic treatment for chronic low back pain and Modic changes. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 25, 2019 Category: Consumer Health News Source Type: news
Amoxicillin (Moxatag) vs. Azithromycin (Zithromax)
Title: Amoxicillin (Moxatag) vs. Azithromycin (Zithromax)Category: MedicationsCreated: 8/7/2019 12:00:00 AMLast Editorial Review: 8/7/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 7, 2019 Category: Drugs & Pharmacology Source Type: news
Nitrofurantoin vs. Amoxicillin
Title: Nitrofurantoin vs. AmoxicillinCategory: MedicationsCreated: 6/27/2019 12:00:00 AMLast Editorial Review: 6/27/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 27, 2019 Category: Drugs & Pharmacology Source Type: news
Amoxicillin vs. Ceftriaxone
Title: Amoxicillin vs. CeftriaxoneCategory: MedicationsCreated: 5/30/2019 12:00:00 AMLast Editorial Review: 5/30/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 30, 2019 Category: Drugs & Pharmacology Source Type: news
Amoxicillin vs. Cipro
Title: Amoxicillin vs. CiproCategory: MedicationsCreated: 5/29/2019 12:00:00 AMLast Editorial Review: 5/29/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 29, 2019 Category: Drugs & Pharmacology Source Type: news
Medical News Today: Augmentin (Amoxicillin/clavulanate potassium)
Augmentin (amoxicillin/clavulanate potassium) is a prescription medication that ’s used to treat infections caused by bacteria. It belongs to a class of drugs called penicillin antibiotics. Augmentin comes as an oral tablet and an oral liquid suspension. Learn about side effects, warnings, dosage, and more. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 17, 2019 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news
How Some Generic Drugs Could Do More Harm Than Good
For the 16 years that Dr. Brian Westerberg, a Canadian surgeon, worked volunteer missions at the Mulago National Referral Hospital in Kampala, Uganda, scarcity was the norm. The patients usually exceeded the 1,500 allotted beds. Running water was once cut off when the debt-ridden hospital was unable to pay its bills. On some of his early trips, Westerberg even brought over drugs from Canada in order to treat patients. But as low-cost generics made in India and China became widely available through Uganda’s government and international aid agencies in the early 2000s, it seemed at first like the supply issue had been ...
Source: TIME: Health - May 17, 2019 Category: Consumer Health News Authors: Katherine Eban Tags: Uncategorized generic drugs medication medicine Source Type: news
Researchers identify faster, more effective drug combination regimens to treat tuberculosis
Tuberculosis is a potentially deadly though curable disease. Each year about 10 million people develop active cases, and 1.6 million people die. In addition, about 1.7 billion people around the world are infected with TB bacteria, which can lie dormant for weeks to years, then become active and cause disease in up to 10 percent of those who are infected.Today, people who contract tuberculosis typically take a course of drugs for six to eight months. However, the length of treatment means some patients don ’t stick with the therapy or may develop adverse effects from drug toxicity. Some may develop resistance to the drugs...
Source: UCLA Newsroom: Health Sciences - May 13, 2019 Category: Universities & Medical Training Source Type: news
Several antibiotics appear effective against early-stage Lyme disease
This meta-analysis suggests that when symptoms of the disease are confined to a localised skin infection, treatment failures are relatively infrequent, only 2% at 12 months. Effective antibiotics include penicillin V, doxycycline, azithromycin, cefuroxime, amoxicillin and ceftriaxone plus doxycycline.The research has significant limitations, but choice, dose and duration of antibiotics appear to have little impact on outcomes. This research does not suggest that guidelines need to be reviewed. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 15, 2019 Category: Consumer Health News Source Type: news
Class 4 defect information: Amoxicillin 500mg Capsules BP
Accord Healthcare has advised that a change to the Patient Information Leaflet for Amoxicillin 500mg Capsules BP has not been implemented by the required timeline. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 4, 2019 Category: Drugs & Pharmacology Source Type: news
Class 4 defect information: Amoxicillin 500mg Capsules BP
Accord Healthcare has advised that a change to the Patient Information Leaflet for Amoxicillin 500mg Capsules BP has not been implemented by the required timeline.
Staytotally up to date with all th (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 4, 2019 Category: Drugs & Pharmacology Source Type: news
